38
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Dynamics of serum angiopoietin-2 levels correlate with efficacy of intravenous pulse cyclophosphamide therapy for interstitial lung disease associated with systemic sclerosis

, , , , , , , , , , , , & show all
Pages 884-890 | Received 23 May 2012, Accepted 22 Aug 2012, Published online: 02 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ryosuke Saigusa, Yoshihide Asano, Kouki Nakamura, Takashi Yamashita, Yohei Ichimura, Takehiro Takahashi, Tetsuo Toyama, Takashi Taniguchi, Ayumi Yoshizaki, Miki Miyazaki, Zenshiro Tamaki & Shinichi Sato. (2017) Plasma plasmin-α2-plasmin inhibitor complex levels may predict the effect of cyclophosphamide for systemic sclerosis-related interstitial lung disease. Modern Rheumatology 27:4, pages 618-622.
Read now

Articles from other publishers (16)

Francesca Motta, Antonio Tonutti, Natasa Isailovic, Angela Ceribelli, Giovanni Costanzo, Stefano Rodolfi, Carlo Selmi & Maria De Santis. (2023) Proteomic aptamer analysis reveals serum biomarkers associated with disease mechanisms and phenotypes of systemic sclerosis. Frontiers in Immunology 14.
Crossref
Francesco Amati, Gabriele Bongiovanni, Antonio Tonutti, Francesca Motta, Anna Stainer, Giuseppe Mangiameli, Stefano Aliberti, Carlo Selmi & Maria De Santis. (2023) Treatable Traits in Systemic Sclerosis. Clinical Reviews in Allergy & Immunology 65:2, pages 251-276.
Crossref
Jia-Min Wang, Wang-Dong Xu, Zhi-Chao Yuan, Qian Wu, Jie Zhou & An-Fang Huang. (2021) Serum levels and gene polymorphisms of angiopoietin 2 in systemic lupus erythematosus patients. Scientific Reports 11:1.
Crossref
Qian Wu, Wang-Dong Xu & An-Fang Huang. (2020) Role of angiopoietin-2 in inflammatory autoimmune diseases: A comprehensive review. International Immunopharmacology 80, pages 106223.
Crossref
Małgorzata Michalska-Jakubus, Maurizio Cutolo, Vanessa Smith & Dorota Krasowska. (2019) Imbalanced serum levels of Ang1, Ang2 and VEGF in systemic sclerosis: Integrated effects on microvascular reactivity. Microvascular Research 125, pages 103881.
Crossref
Yuki Fukui, Takuya Miyagawa, Megumi Hirabayashi, Takashi Yamashita, Ryosuke Saigusa, Shunsuke Miura, Kouki Nakamura, Ayumi Yoshizaki, Shinichi Sato & Yoshihide Asano. (2019) Possible association of decreased serum CXCL 14 levels with digital ulcers in patients with systemic sclerosis . The Journal of Dermatology 46:7, pages 584-589.
Crossref
Takashi Yamashita, Yoshihide Asano, Ryosuke Saigusa, Takashi Taniguchi, Megumi Hirabayashi, Takuya Miyagawa, Kouki Nakamura, Shunsuke Miura, Ayumi Yoshizaki, Maria Trojanowska & Shinichi Sato. (2019) Cyclophosphamide Pulse Therapy Normalizes Vascular Abnormalities in a Mouse Model of Systemic Sclerosis Vasculopathy. Journal of Investigative Dermatology 139:5, pages 1150-1160.
Crossref
Hayakazu Sumida, Yoshihide Asano, Zenshiro Tamaki, Naohiko Aozasa, Takashi Taniguchi, Tetsuo Toyama, Takehiro Takahashi, Yohei Ichimura, Shinji Noda, Kaname Akamata, Ryosuke Saigusa, Miki Miyazaki, Yoshihiro Kuwano, Koichi Yanaba, Ayumi Yoshizaki & Shinichi Sato. (2018) Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study. The Journal of Dermatology 45:12, pages 1425-1433.
Crossref
T. Takahashi, Y. Asano, T. Yamashita, K. Nakamura, R. Saigusa, S. Miura, Y. Ichimura, T. Toyama, M. Hirabayashi, T. Taniguchi, A. Yoshizaki & S. Sato. (2018) A potential contribution of psoriasin to vascular and epithelial abnormalities and inflammation in systemic sclerosis. Journal of the European Academy of Dermatology and Venereology 32:2, pages 291-297.
Crossref
Takashi Taniguchi, Yoshihide Asano, Kouki Nakamura, Takashi Yamashita, Ryosuke Saigusa, Yohei Ichimura, Takehiro Takahashi, Tetsuo Toyama, Ayumi Yoshizaki & Shinichi Sato. (2017) Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic Sclerosis. The Journal of Rheumatology 44:8, pages 1198-1205.
Crossref
T. Takahashi, Y. Asano, K. Nakamura, T. Yamashita, R. Saigusa, Y. Ichimura, T. Toyama, T. Taniguchi, A. Yoshizaki, Z. Tamaki, Y. Tada, M. Sugaya, T. Kadono & S. Sato. (2016) A potential contribution of antimicrobial peptide LL-37 to tissue fibrosis and vasculopathy in systemic sclerosis. British Journal of Dermatology 175:6, pages 1195-1203.
Crossref
Kouki Nakamura, Yoshihide Asano, Takashi Taniguchi, Shun Minatsuki, Toshiro Inaba, Hisataka Maki, Masaru Hatano, Takashi Yamashita, Ryosuke Saigusa, Yohei Ichimura, Takehiro Takahashi, Tetsuo Toyama, Ayumi Yoshizaki, Tomomitsu Miyagaki, Makoto Sugaya & Shinichi Sato. (2016) Serum levels of interleukin‐18‐binding protein isoform a: Clinical association with inflammation and pulmonary hypertension in systemic sclerosis. The Journal of Dermatology 43:8, pages 912-918.
Crossref
Iman H. Bassyouni, Mohammed Sharaf, Iman E. Wali & Hossam M. Mansour. (2015) Clinical significance of Angiopoietin-1 in Behcet?s disease patients with vascular involvement. Heart and Vessels 31:6, pages 918-924.
Crossref
Masahiro Uehara, Noriyuki Enomoto, Masashi Mikamo, Yoshiyuki Oyama, Masato Kono, Tomoyuki Fujisawa, Naoki Inui, Yutaro Nakamura & Takafumi Suda. (2016) Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis. Respiratory Medicine 114, pages 18-26.
Crossref
Takashi Yamashita, Yoshihide Asano, Takashi Taniguchi, Kouki Nakamura, Ryosuke Saigusa, Takehiro Takahashi, Yohei Ichimura, Tetsuo Toyama, Ayumi Yoshizaki, Tomomitsu Miyagaki, Makoto Sugaya & Shinichi Sato. (2016) A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis. Experimental Dermatology 25:4, pages 287-292.
Crossref
Nargues Weir & Virginia Steen. 2014. Pulmonary Manifestations of Rheumatic Disease. Pulmonary Manifestations of Rheumatic Disease 37 47 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.